info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
 
Home » Healthcare » Multiplex Assays Market Size, Growth | Forecast 2030

Multiplex Assays Market: By Product and Service (Instruments, Consumables, Software and Services), By Technology (Fluorescence Detection, Luminescence, Flow Cytometry, Multiplex Real-Time PCR, Others), By Geography, Segment revenue estimation, Forecast, 2021-2030

Published On: Mar-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 20673916

Industry Report and Statistics (Facts & Figures) - Sales Volume & ASP by Product Type & Technology

The global multiplex assays market will witness a robust CAGR of 7.53%, valued at $3.36 billion in 2021, expected to appreciate and reach $6.47 billion by 2030, confirms Strategic Market Research. The multiplex assay is one of the most crucial derivatives of an ELISA, using beads to bind the "capture" antibody. The "capture" antibody helps bind and retain the sample analyte.

Multiplex Assays Market Infographics

Key Industry Drivers - Rising numbers of NCDs and Infectious Diseases and the Increase in the Use of Multiplex Assays in Companion Diagnostics

  • The continuous rising prevalence of chronic (non-communicable) and infectious diseases across the globe is one of the major factors that augment the overall market growth throughout the estimated time frame. According to the World Health Organization, chronic/ non-communicable diseases (NCD) kill 41 Mn people each year, which is equivalent to 71% of all the deaths occurring globally. Each year, more than 15 million people between the ages of (30 to 69) die due to an NCD. Approximately 85% of these "premature" deaths occur in middle and low-income countries. CVDs (cardiovascular diseases) are the most common type of NCD, which leads to the highest number of deaths worldwide (i.e., 17.9 Mn people annually), followed by cancers (9.3 Mn), respiratory diseases (4.1 Mn), and diabetes (1.5 Mn). Also, as per the National Institutes of Health, 5 types of infectious diseases are ranked among the top ten killer diseases worldwide, namely lower respiratory infections diseases (3.4 Mn deaths), HIV/AIDS (2.6 Mn deaths), diarrheal diseases (1.8 Mn deaths), tuberculosis (1.6 Mn deaths), and malaria (1.1 Mn deaths).

 

  • Apart from the increase of chronic and infectious diseases, the rising awareness of disease diagnosis and the rising prevalence of multiplex assays in companion diagnostics, the requirement for effective analytical platforms in R&D is propelling the overall market growth significantly.

 

  • Further, the rise in usage of several advanced technologies and processes like multiplex bead array assays, map assay, Invitrogen Luminex, cytokine immunoassay, multiplex Merck, RNA scope v2, magpix assay, msd cytokine multiplex, magpix cytokine assay, rnascope multiplex fluorescent v2 assay, multiplex assays, xmap luminex, multiplex assays ELISA, etc. are fuelling the growth of the market worldwide.

multiplex assays market by share 2020-2030

Restraints - Expensive Equipment & Stringent Regulations

  • The higher equipment costs are one of the major factors restraining the overall multiplex assays market growth, as it constantly challenges the manufacturers and researchers to perform multiplex assay testing at an affordable cost. 

  • Also, the standards for Quality control (Q.C.) of the multiplex assays are more stringent than the single-plex assays, thereby obstructing the overall market growth.

 

Opportunities - The Increase in the Need for Automated Systems and the Rising Prevalence of the Biomarkers in Protein and Molecular Diagnostics in the Asia-Pacific Region

  • Multiple biomarker analysis has a major application in the area of autoimmune diseases, cancer, and neurodegenerative diseases. With the discovery of many biomarkers, there is a higher probability of developing new diagnostic tests in the Asia-Pacific region, which is expected to create ample growth opportunities in the future. 

  • Also, the latest development in the Technology of an automated multiplex assay instrument is expected to boost the overall market growth, which will help the market grow exponentially in the future.

 

multiplex assays market by application 2020-2030

Market Analysis Of Different Segments Covered in the Report

Based on Product and Service

  • Instruments

  • Consumables

  • Software and Services

 

Based on Type

  • Nucleic Acid Multiplex Assays

    • Planar Nucleic Acid Assays

    • Bead-Based Nucleic Acid Assays

    • Others

  • Protein Multiplex Assays

    • Planar Protein Assays

    • Bead-Based Protein Assays

    • Others

  • Cell-Based Multiplex Assays

 

Based on Technology

  • Fluorescence Detection

  • Luminescence

  • Flow Cytometry

  • Multiplex Real-Time PCR

  • Others

 

Based on Applications

  • Research & Development

    • Biomarker Discovery & Validation

    • Drug Discovery & Development

  • Clinical Diagnostics

    • Cancer

    • Cardiovascular Diseases

    • Infectious Diseases

    • Autoimmune Diseases

    • Metabolism & Endocrinology Disorders

    • Nervous System Disorders

    • Others

 

Based on End-User

  • Hospitals & Research Institutes

  • Pharmaceutical & Biotechnology Companies

  • Reference Laboratories

  • Others

 

Regional Coverage Analysis

North America

  • United States

  • Mexico

  • Canada

  • Rest of North America

 

Europe

  • Switzerland

  • Russia

  • France

  • Germany

  • U.K

  • Finland

  • Turkey

  • Netherlands 

  • Belgium

  • Spain

  • Italy

  • Rest of Europe

 

Asia Pacific

  • China

  • India

  • Indonesia

  • South Korea

  • Thailand

  • Japan

  • Singapore

  • Malaysia

  • Philippines

  • Australia

  • New Zealand

  • Rest of APAC

 

LAMEA

  • Brazil

  • Saudi Arabia

  • Uruguay

  • Argentina

  • Rest of LAMEA

 

multiplex assays market by end user 2020-2030

Based on Product & Service, the 'Consumables' segment held the highest share of almost 44.27% of the entire multiplex assays market in 2020. It also held the fastest growth rate with a decent CAGR throughout the forecasted period. The vital factors like the higher usage of reagents for facilitating research applications on consumables and the increase in the number of recurring purchases of assays worldwide are fuelling this segment's overall growth.

 

Based on Type, the 'Protein Multiplex Assays' segment dominated the overall market with a steady CAGR during the estimated period owing to the sheer focus on proteomics studies for clinical diagnostics and biomarker research. According to IBISWorld, in 2021, there will be about 28,393 Diagnostic & Medical Laboratory businesses in the United States, with an increase of nearly 1.5 percent from 2020.

 

Based on Technology, the 'Flow Cytometry segment held the largest share (approximately 37.28%) of the entire market in 2020, with a decent CAGR of 8.27%. The largest share of this segment can primarily be attributed to the wide range of flow cytometry applications in the measurement and detection of RNA, protein expression, and cell viability & toxicity, along with the identification and characterization of various cell types.

 

Based on Applications, the 'Research & Development segment dominated the market in 2020 due to the increase of funds by the worldwide governments for the broad applications of multiplex assay technologies in R&D functions. The R&D outsourcing services market is accelerating at a CAGR of 7.93%, which in turn is propelling the overall growth of this segment.

 

Based on End Users, the 'Pharmaceutical & Biotechnology Companies' segment accounted for the highest market share in 2020. Factors such as the rising focus of biotechnological companies on developing monoclonal and biosimilars antibodies and the increase in the number of adoptions of multiplex assays in the field of drug discovery by pharmaceuticals are significantly driving the overall growth of this segment.

 

Based on Regions, North America held the largest regional market share with a CAGR of 8.93% in 2020, followed by Europe. The highest share of the North American region can primarily be attributed to the presence of leading pharmaceutical and biotechnology companies, established pharmaceutical industries, and increased R&D expenditures by the government. Multiplex assays market is significantly higher in the United States than in any other country. In addition, the government spending on the clinical services laboratory has increased by approximately 5.23% between 2010 to 2020, which has highly boosted the market in the United States.

 

Global Multiplex Assays Market Competitive Landscape Analysis

The competitive landscape analysis provides information about the crucial competitors prevailing in the worldwide market environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc.

  • Luminex Corporation

  • Illumina Inc

  • Bio-Rad Laboratories, Inc.

  • Qiagen N.V.

  • Thermo Fisher Scientific Inc

  • Abcam plc

  • Merck KGaA

  • Agilent Technologies, Inc.

  • Becton, Dickinson, and Company

  • Meso Scale Diagnostics

  • Randox Laboratories

  • Quanterix

  • Bio-Techne Corporation

  • Olink

  • DiaSorin S.p.A.

  • Seegene

  • Promega Corporation

  • Siemens Healthineers

  • PerkinElmer Inc.

  • Shimadzu Biotech

  • Antigenix America, Inc.

  • Enzo Life Sciences, Inc.

  • Boster Biological Technology

  • AYOXXA Biosystems GmbH

  • Cayman Chemical Company

 

Multiplex Assays Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 3.36 billion

The revenue forecast in 2030

USD 6.47 billion

Growth rate

CAGR of approximately 7.53%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

Based on Product & Service, Type, Technology, Applications, End-User, and Regions.

Based on Product & Service

Instruments, Consumables, Software and Services

Based on Type

Nucleic Acid Multiplex Assays (Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays, Others), Protein Multiplex Assays (Planar Protein Assays, Bead-Based Protein Assays, Others), Cell-Based Multiplex Assays

Based on Technology

Fluorescence Detection, Luminescence, Flow Cytometry, Multiplex Real-Time PCR, Others

Based on Applications

Research & Development (Biomarker Discovery & Validation, Drug Discovery & Development), Clinical Diagnostics (Cancer, Cardiovascular Diseases, Infectious Diseases, Autoimmune Diseases, Metabolism & Endocrinology Disorders, Nervous System Disorders, Others)

Based on End-User

Hospitals & Research Institutes, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Others

Based on Regions

North America, Europe, Asia Pacific, LAMEA

Country Scope

United States of America, Mexico, United Arab Emirates, United Kingdom, Germany, France, Canada, China, India, Japan, South Korea, Brazil, Argentina, Saudi Arabia, South Africa

Company Usability Profiles

Luminex Corporation, Illumina Inc, Bio-Rad Laboratories, Inc, Qiagen N.V, Thermo Fisher Scientific Inc, Abcam plc, Merck KGaA, Agilent Technologies, Inc, Becton, Dickinson, and Company, Meso Scale Diagnostics, Randox Laboratories, Quanterix, Bio-Techne Corporation, Olink, DiaSorin S.p.A., Seegene, Promega Corporation, Siemens Healthineers, PerkinElmer Inc., Shimadzu Biotech, Antigenix America, Inc., Enzo Life Sciences, Inc., Boster Biological Technology, AYOXXA Biosystems GmbH, Cayman Chemical Company

 

multiplex assays market by region 2020-2030

Recent Developments

  • On August 2021, Becton, Dickinson, and Company launched its new automated high-throughput diagnostic BD COR System. The system uses sample management software algorithms and robotics technology to set up a new standard in molecular testing automation for infectious diseases in core laboratories in the United States.

  • On April 2021, Illumina successfully acquired GRAIL; a world-renowned healthcare company focused on providing early life-saving detection of multiple types of cancers. However, Illumina will hold GRAIL as a separate company during the European Commission's ongoing regulatory review.

  • On February 2021, Thermo Fisher Scientific succeeded in acquiring Mesa Biotech, a privately held POC (point-of-care) molecular diagnostic company. By combining Thermo Fisher's excellence in operations, existing sales and distribution channels with Mesa's innovative platform, and direct access to the raw materials, rapid scaling of manufacturing volume can be performed easily.

 

The List of Key Products that Global Market Leaders Develop

PRODUCT NAME

FUNCTION

COMPANY

Invitrogen Instant ELISA kits

The instant ELISA Kits have ready-to-use plates that contain all the necessary assay components like lyophilized detection antibody, capture antibody, sample diluent, and streptavidin-HRP. These plates help in the reduction of pipetting time and also enable a simple one-wash type of protocol.

Thermo Fisher Scientific Inc

Human IL-6 ELISA Kit II

It is designed in such a brilliant way that it can successfully measure the total amount of targeted bound between a matched pair of antibodies.

Becton, Dickinson, and Company

 

SIMOA

Acts as an accelerator or catalyst in the Laboratory for Protein biomarker testing processes.

Quanterix

ADVIA Centaur XPT Immunoassay System

It is one of the highest-throughput systems that can ever be available. It delivers the perfect results that the clinicians depend upon for better patient care and accurate diagnoses.

Siemens Healthineers

 

 

Frequently Asked Question About This Report

The global multiplex assays market size was $3.36 billion in 2021 and is predicted to reach $6.47 billion by 2030, with a CAGR of 7.53%.

Based on Product and Service, the Consumables segment held the highest share of almost 44.27% of the entire market in 2020.

Based on End User, the Pharmaceutical & Biotechnology Companies segment accounted for the highest market share in 2020.

The global multiplex assays market is expected to grow at a compound annual growth rate (CAGR) of 7.53% from 2021 to 2030 to reach USD 6.47 billion by 2030.

The most vital players of the market are Luminex Corporation, Illumina Inc, Bio-Rad Laboratories, Inc, Qiagen N.V., Thermo Fisher Scientific Inc, Abcam plc, Merck KGaA, Agilent Technologies, Inc, Becton, Dickinson and Company, Meso Scale Diagnostics, Randox Laboratories, Quanterix, Bio-Techne Corporation, Olink, DiaSorin S.p.A., Seegene, Promega Corporation, Siemens Healthineers, PerkinElmer Inc, Shimadzu Biotech, Antigenix America, Inc, Enzo Life Sciences, Inc, Boster Biological Technology, AYOXXA Biosystems GmbH, and Cayman Chemical Company.

 


Sources

https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

https://news.bd.com/2021-08-25-BD-Launches-Fully-Automated-High-Throughput-Molecular-Diagnostic-Platform-for-U-S-Laboratories


 

1.   Introduction

       1.1.  Study Objective

       1.2.  Market Definition        

       1.3.  Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1.  Data Procurement

       2.2.  Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3.  Market Size Estimation

       2.4.  Bottom-Up and Top-Down Approaches

              2.4.1.       Bottom-Up Approach

                     2.4.1.1.            Approach for arriving at market size by bottom-up analysis

              2.4.2.       Top-Down Approach

                     2.4.2.1.            Approach for Capturing Market Size by Top-Down Analysis

       2.5.  Market Breakdown and Data Triangulation

       2.6.  Research Methodology

       2.7.  Risk Assessment

3.  Executive Summary

       3.1   Post-Covid-19

              3.1.1        Actual Scenario

              3.1.2        Pessimistic Scenario

              3.1.3        Optimistic Scenario

              3.1.4        Market Summary

4. Industry Outlook

       4.1   Market Snapshot

       4.2   Global Multiplex Assays Market

              4.2.1        Global  market, 2021 – 2030 (USD Million)

       4.3   Regional Business Analysis

              4.3.1        Global  market, by region, 2021 - 2030 (USD Million)

       4.4   By Product and Service Analysis

              4.4.1        Global  market, By Product and Service, 2021 - 2030 (USD Million)

       4.5   By Technology Business Analysis

              4.5.1        Global  market, By Technology, 2021 - 2030 (USD Million)

       4.6   By Type Analysis

              4.6.1        Global  market, By Type, 2021 - 2030 (USD Million)

     4.7     By End-User Business Analysis

              4.7.1        Global  market,  By End-User, 2021 - 2030 (USD Million)

       4.8   Application Business Analysis

              4.8.1        Global  market, By Application, 2021 - 2030 (USD Million)

       4.9   Value Chain Analysis

       4.10 Market Variable Analysis

              4.10.1      Market Drivers Analysis

              4.10.2      Market Restraints Analysis

       4.11 Business Environment Analysis Tool

              4.11.1       market PEST analysis

              4.11.2       market Porter’s analysis

       4.12 Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1.  Introduction

       5.2.  Market Dynamics

              5.2.1.       Drivers

              5.2.2.       Restraints

              5.2.3.       Opportunities

              5.2.4.       Challenges

       5.3.  Impact of Covid-19 On  Market

       5.4.  Value Chain Analysis

       5.5.  Ecosystem

       5.6.  Patent Analysis

       5.7.  Trade Analysis

       5.8.  Tariff Analysis

       5.9.  Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1      Threat of New Entrants

              5.10.2      Threat of Substitutes

              5.10.3      Bargaining Power of Buyers

              5.10.4      Bargaining Power of Suppliers

              5.10.5      Degree of Competition

       5.11.               Technology Analysis

              5.11.1.     Trends in Technology (2014-2021)

              5.11.2.     Trends in Technology (2021-2030)

       5.12.               Pricing Analysis

              5.12.1.     Average Price Trend Analysis (By Region, By Country)

6. Competitive & Vendor Landscape

       6.1.  Company Market Share Analysis

       6.2.  Manufacturers  Manufacturing Sites, Area Served, Product Type

       6.3.   Market Competitive Situation and Trends

       6.4.  Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global  Market:  By Product and Service Segment Analysis

       7.1.  Introduction

       7.2.  Sales Volume & Revenue Analysis (2021-2030)

       7.3.  Instruments

              7.3.1. Instruments market, 2021 - 2030 (USD Million)

       7.4.  Consumables

              7.4.1. Consumables market, 2021 - 2030 (USD Million)

      7.5 Software and Services

             7.5.1 Software and Services market, 2021 - 2030 (USD Million)

8. Global  Market: By Technology Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Fluorescence Detection

              8.3.1. Fluorescence Detection market, 2021 - 2030 (USD Million)

       8.4. Luminescence

              8.4.1. Luminescence market, 2021 - 2030 (USD Million)

       8.5 Flow Cytometry

              8.5.1 Flow Cytometry market, 2021 - 2030 (USD Million)

       8.6 Multiplex Real-Time PCR

              8.6.1 Multiplex Real-Time PCR market, 2021 - 2030 (USD Million)

       8.7 Others

              8.7.1 Others market, 2021 - 2030 (USD Million)

9. Global  Market: By Type Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Nucleic Acid

              9.3.1. Nucleic Acid  market, 2021 - 2030 (USD Million)

                     9.3.1.1 Planar Nucleic Acid Assays market, 2021 - 2030 (USD Million)

                     9.3.1.2 Bead-Based Nucleic Acid Assays market, 2021 - 2030 (USD Million)

                     9.3.1.3 Others market, 2021 - 2030 (USD Million)

       9.4. Protein

              9.4.1. Protein  market, 2021 - 2030 (USD Million)

                     9.4.1.1 Planar Protein Assays market, 2021 - 2030 (USD Million)

                     9.4.1.2 Bead-Based Protein Assays market, 2021 - 2030 (USD Million)

                     9.4.1.3 Others market, 2021 - 2030 (USD Million)

       9.5 Cell-Based

              9.5.1 Cell-Based  market, 2021 - 2030 (USD Million)

10. Global  Market: By End-User Segment Analysis

       10.1. Introduction

       10.2. Sales Volume & Revenue Analysis (2021-2030)

       10.3. Hospitals & Research Institutes

              10.3.1. Hospitals & Research Institutes Market, 2021 - 2030 (USD Million)

       10.4. Pharmaceutical & Biotechnology Companies

              10.4.1. Pharmaceutical & Biotechnology Companies market, 2021 - 2030 (USD Million)

       10.5 Reference Laboratories

              10.5.1 Reference Laboratories market, 2021 - 2030 (USD Million)

       10.6 Others

              10.6.1 Others market, 2021 - 2030 (USD Million)

11. Global  Market: By Application Segment Analysis

      11.1. Introduction

       11.2. Sales Volume & Revenue Analysis (2021-2030)

       11.3. Research & Development

             11.3.1. Research & Development market, 2021 - 2030 (USD Million)

                    11.3.1.1 Biomarker Discovery & Validation market, 2021 - 2030 (USD Million)

                    11.3.1.1 Drug Discovery & Development market, 2021 - 2030 (USD Million)

       11.4. Clinical Diagnostics

              11.4.1. Clinical Diagnostics market, 2021 - 2030 (USD Million)

                     11.4.1.1 Cancer market, 2021 - 2030 (USD Million)

                     11.4.1.2 Cardiovascular Diseases market, 2021 - 2030 (USD Million)

                     11.4.1.3 Infectious Diseases market, 2021 - 2030 (USD Million)

                     11.4.1.4 Autoimmune Diseases market, 2021 - 2030 (USD Million)

                     11.4.1.5 Metabolism & Endocrinology Disorders market, 2021 - 2030 (USD Million)

                     11.4.1.6 Nervous System Disorders market, 2021 - 2030 (USD Million)

                     11.4.1.7 Others market, 2021 - 2030 (USD Million)

12. Global  Market: Regional Outlook

       12.1 North America

              12.1.1.     North America market, By End-User, 2021 - 2030 (USD Million)

              12.1.4.     North America market, By Application, 2021 - 2030 (USD Million)

 

              12.1.5.     North America market, by Country, 2021 - 2030 (USD Million)

12.1.4.1.               U.S.

                     12.1.4.1.1.      U.S. market, By End-User, 2021 - 2030 (USD Million)

    12.1.4.2.      Canada

                     12.1.4.2.1.      Canada market, By End-User, 2021 - 2030 (USD Million)

                     12.1.4.2.2.      Canada market, By Region, 2021 - 2030 (USD Million)

                     12.1.4.2.3.      Canada market, by Applications, 2021 - 2030 (USD Million)

12.2.      Europe

              12.2.1.     Europe market, By End-User, 2021 - 2030 (USD Million)

              12.2.2.     Europe market, by  By Application, 2021 - 2030 (USD Million)

             12.2.5.      Europe market, by country, 2021 - 2030 (USD Million)

   12.2.4.1    U.K.

                     12.2.4.1.1.      U.K. market, By End-User, 2021 - 2030 (USD Million)

                    12.2.4.1.2.       U.K. market, By Applications, 2021 - 2030 (USD Million)

                     12.2.4.1.3.      U.K. market, by Region, 2021 - 2030 (USD Million)

   12.2.4.2.            Germany

                     12.2.4.2.1.      Germany market, By End-User, 2021 - 2030 (USD Million)

                     12.2.4.2.2.      Germany market, By Application, 2021 - 2030 (USD Million)

                     12.2.4.2.3.      Germany market, by Region, 2021 - 2030 (USD Million)

   12.2.4.3.            France

                     12.2.4.3.1.      France market, By End-User, 2021 - 2030 (USD Million)

                     12.2.4.3.2.      France market, By Region, 2021 - 2030 (USD Million)

                     12.2.4.3.3.      France market, by Application, 2021 - 2030 (USD Million)

    12.2.4.4.           Rest of Europe

                     12.2.4.4.1.      Rest of Europe market, By End-User, 2021 - 2030 (USD Million)

                     12.2.4.4.2.      Rest of Europe market, By Region, 2021 - 2030 (USD Million)

                     12.2.4.4.3.      Rest of Europe market, by Application, 2021 - 2030 (USD Million)

       12.3.               Asia Pacific

              12.3.1.     Asia Pacific market, By End-User, 2021 - 2030 (USD Million)

              12.3.2.     Asia Pacific market, By Application, 2021 - 2030 (USD Million)

             12.3.5.      Asia Pacific market, by country, 2021 - 2030 (USD Million)

   12.3.4.1.            China

                     12.3.4.1.1.      China market, By End-User, 2021 - 2030 (USD Million)

                     12.3.4.1.2.      China market, By Region, 2021 - 2030 (USD Million)

                     12.3.4.1.3.      China market, by Application, 2021 - 2030 (USD Million)

   12.3.4.2.            India

                     12.3.4.2.1.      India market, By End-User, 2021 - 2030 (USD Million)

                     12.3.4.2.2.      India market, By Region, 2021 - 2030 (USD Million)

                     12.3.4.2.3.      India market, by Application, 2021 - 2030 (USD Million)

   12.3.4.3.            Japan

                     12.3.4.3.1.      Japan market, By End-User, 2021 - 2030 (USD Million)

                     12.3.4.3.3.      Japan market, by Application, 2021 - 2030 (USD Million)

   12.3.4.4.            South Korea

                     12.3.4.4.1.      South Korea market, By End-User, 2021 - 2030 (USD Million)

                     12.3.4.4.3.      South Korea market, by Application, 2021 - 2030 (USD Million)

12.3.4.5.             Rest of ASIA PACIFIC

                     12.3.4.5.1.      Rest of ASIA PACIFIC market, By End-User, 2021 - 2030 (USD Million)

                     12.3.4.5.3.      Rest of ASIA PACIFIC market, by Application, 2021 - 2030 (USD Million)

       12.4.               Latin America

              12.4.1.     Latin America market, By End-User, 2021 - 2030 (USD Million)

              12.4.3.     Latin America market, by Application, 2021 - 2030 (USD Million)

              12.4.4.     Latin America market, by country, 2021 - 2030 (USD Million)

12.4.4.1.               Brazil

                     12.4.4.1.1.      Brazil market, By End-User, 2021 - 2030 (USD Million)

                     12.4.4.1.3.      Brazil market, by Application, 2021 - 2030 (USD Million)

12.4.4.2.               Mexico

                     12.4.4.2.1.      Mexico market, By End-User, 2021 - 2030 (USD Million)

                     12.4.4.2.3.      Mexico market, by Application, 2021 - 2030 (USD Million)

  12.4.4.3.             Rest of the Latin America

                     12.4.4.3.1.      Rest of the Latin America market, By End-User, 2021 - 2030 (USD Million)

                     12.4.4.3.3.      Rest of the Latin America market, by Application, 2021 - 2030 (USD Million)

13. Competitive Landscape

       13.1 Luminex Corporation

              13.1.1.     Company overview

              13.1.2.     Financial performance

              13.1.3.     Product Portfolio Analysis

              13.1.4.     Business Strategy & Recent Development

       13.2. Illumina Inc

              13.2.1.     Company overview

              13.2.2.     Financial performance

              13.2.3.     Product Portfolio Analysis

              13.2.4.     Business Strategy & Recent Development

       13.3. Bio-Rad Laboratories, Inc.

              13.3.1.     Company overview

              13.3.2.     Financial performance

              13.3.3.     Product Portfolio Analysis

              13.3.4.     Business Strategy & Recent Development

       13.4. Qiagen N.V.

              13.4.1.     Company overview

              13.4.2.     Financial performance

              13.4.3.     Product Portfolio Analysis

              13.4.4.     Business Strategy & Recent Development

       13.5. Thermo Fisher Scientific Inc

              13.5.1.     Company overview

              13.5.2.     Financial performance

              13.5.3.     Product Portfolio Analysis

              13.5.4.     Business Strategy & Recent Development

       13.6. Abcam plc

              13.6.1.     Company overview

              13.6.2.     Financial performance

              13.6.3.     Product Portfolio Analysis

              13.6.4.     Business Strategy & Recent Development

       13.7. Merck KGaA

              13.7.1.     Company overview

              13.7.2.     Financial performance

              13.7.3.     Product Portfolio Analysis

              13.7.4.     Business Strategy & Recent Development

       13.8. Agilent Technologies, Inc.

              13.8.1.     Company overview

              13.8.2.     Financial performance

              13.8.3.     Product Portfolio Analysis

              13.8.4.     Business Strategy & Recent Development

       13.9. Becton, Dickinson, and Company

              13.9.1.     Company overview

              13.9.2.     Financial performance

              13.9.3.     Product Portfolio Analysis

              13.9.4.     Business Strategy & Recent Development

       13.10. Meso Scale Diagnostics

              13.10.1.  Company overview

              13.10.2.  Financial performance

              13.10.3.  Product Portfolio Analysis

              13.10.4.  Business Strategy & Recent Development

       13.11. Randox Laboratories

              13.11.1.  Company overview

              13.11.2.  Financial performance

              13.11.3.  Product Portfolio Analysis

              13.11.4.  Business Strategy & Recent Development

       13.12. Quanterix

              13.12.1.  Company overview

              13.12.2.  Financial performance

              13.12.3.  Product Portfolio Analysis

              13.12.4.  Business Strategy & Recent Development

       13.13. Bio-Techne Corporation

              13.13.1.  Company overview

              13.13.2.  Financial performance

              13.13.3.  Product Portfolio Analysis

              13.13.4.  Business Strategy & Recent Development

       13.14. Olink

              13.14.1.  Company overview

              13.14.2.  Financial performance

              13.14.3.  Product Portfolio Analysis

              13.14.4.  Business Strategy & Recent Development

       13.15. DiaSorin S.p.A.

              13.15.1.  Company overview

              13.15.2.  Financial performance

              13.15.3.  Product Portfolio Analysis

              13.15.4.  Business Strategy & Recent Development

       13.16. Seegene

              13.16.1.  Company overview

              13.16.2.  Financial performance

              13.16.3.  Product Portfolio Analysis

              13.16.4.  Business Strategy & Recent Development

       13.17. Promega Corporation

              13.17.1.  Company overview

              13.17.2.  Financial performance

              13.17.3.  Product Portfolio Analysis

              13.17.4.  Business Strategy & Recent Development

       13.18. Siemens Healthineers

              13.18.1.  Company overview

              13.18.2.  Financial performance

              13.18.3.  Product Portfolio Analysis

              13.18.4.  Business Strategy & Recent Development

       13.19. PerkinElmer Inc.

              13.19.1.  Company overview

              13.19.2.  Financial performance

              13.19.3.  Product Portfolio Analysis

              13.19.4.  Business Strategy & Recent Development

       13.20. Shimadzu Biotech

              13.20.1.  Company overview

              13.20.2.  Financial performance

              13.20.3.  Product Portfolio Analysis

              13.20.4.  Business Strategy & Recent Development

       13.21. Antigenix America, Inc.

              13.21.1.  Company overview

              13.21.2.  Financial performance

              13.21.3.  Product Portfolio Analysis

              13.21.4.  Business Strategy & Recent Development

       13.22. Enzo Life Sciences, Inc.

              13.22.1.  Company overview

              13.22.2.  Financial performance

              13.22.3.  Product Portfolio Analysis

              13.22.4.  Business Strategy & Recent Development

       13.23. Boster Biological Technology

              13.23.1.  Company overview

              13.23.2.  Financial performance

              13.23.3.  Product Portfolio Analysis

              13.23.4.  Business Strategy & Recent Development

       13.24. AYOXXA Biosystems GmbH

              13.24.1.  Company overview

              13.24.2.  Financial performance

              13.24.3.  Product Portfolio Analysis

              13.24.4.  Business Strategy & Recent Development

       13.25. Cayman Chemical Company

              13.25.1.  Company overview

              13.25.2.  Financial performance

              13.25.3.  Product Portfolio Analysis

              13.25.4.  Business Strategy & Recent Development

 

List of Tables (86 Tables)

TABLE 1.   MARKET, By Product and Service, 2021-2030 (USD Million)

TABLE 2.  MARKET FOR Instruments, BY REGION, 2021-2030 (USD Million)

TABLE 3.  MARKET FOR Consumables, BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET FOR Software and Services, BY REGION, 2021-2030 (USD Million)

TABLE 5.  MARKET, By Technology, 2021-2030 (USD Million)

TABLE 6.  MARKET FOR Fluorescence Detection, BY REGION, 2021-2030 (USD Million)

TABLE 7.  MARKET FOR Luminescence, BY REGION, 2021-2030 (USD Million)

TABLE 8.  MARKET FOR Flow Cytometry, BY REGION, 2021-2030 (USD Million)

TABLE 9.  MARKET FOR Multiplex Real-Time PCR, BY REGION, 2021-2030 (USD Million)

TABLE 10. MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 11.  MARKET, By Type, 2021-2030 (USD Million)

TABLE 12.  MARKET FOR Nucleic Acid, BY REGION, 2021-2030 (USD Million)

TABLE 13.  MARKET FOR Protein, BY REGION, 2021-2030 (USD Million)

TABLE 14.  MARKET FOR Cell-Based, BY REGION, 2021-2030 (USD Million)

TABLE 15.  MARKET,  By End-User, 2021-2030 (USD Million)

TABLE 16.  MARKET  FOR Hospitals & Research Institutes, BY REGION, 2021-2030 (USD Million)

TABLE 17.  MARKET FOR Pharmaceutical & Biotechnology Companies, BY REGION, 2021-2030 (USD Million)

TABLE 18.  MARKET FOR Reference Laboratories, BY REGION, 2021-2030 (USD Million)

TABLE 19.  MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 20. MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 21. MARKET FOR Research & Development, BY REGION, 2021-2030 (USD Million)

TABLE 22. MARKET FOR Clinical Diagnostics, BY REGION, 2021-2030 (USD Million)

TABLE 23. MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 24. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 25. NORTH AMERICA MARKET, BY Applications, 2021-2030 (USD Million)

TABLE 26. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million)

TABLE 27. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 28. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 29. EUROPE MARKET, By End-User, 2021-2030 (USD Million)

TABLE 30. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 31. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 32. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million)

TABLE 33. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 34. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 35. LAMEA MARKET, By End-User, 2021-2030 (USD Million)

TABLE 36. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 37. Luminex Corporation: COMPANY SNAPSHOT

TABLE 38. Luminex Corporation: OPERATING SEGMENTS

TABLE 39. Illumina Inc: COMPANY SNAPSHOT

TABLE 40. Illumina Inc: OPERATING SEGMENTS

TABLE 41. Bio-Rad Laboratories, Inc: COMPANY SNAPSHOT

TABLE 42. Bio-Rad Laboratories, Inc: OPERATING SEGMENTS

TABLE 43. Qiagen N.V.: COMPANY SNAPSHOT

TABLE 44. Qiagen N.V.: OPERATING SEGMENTS

TABLE 45. Thermo Fisher Scientific Inc: COMPANY SNAPSHOT

TABLE 46. Thermo Fisher Scientific Inc: OPERATING SEGMENTS

TABLE 47. Abcam plc: COMPANY SNAPSHOT

TABLE 48. Abcam plc: OPERATING SEGMENTS

TABLE 49. Merck KGaA: COMPANY SNAPSHOT

TABLE 50. Merck KGaA: OPERATING SEGMENTS

TABLE 51. Agilent Technologies, Inc: COMPANY SNAPSHOT

TABLE 52. Agilent Technologies, Inc: OPERATING SEGMENTS

TABLE 53. Becton, Dickinson, and Company: COMPANY SNAPSHOT

TABLE 54. Becton, Dickinson, and Company: OPERATING SEGMENTS

TABLE 55. Meso Scale Diagnostics: COMPANY SNAPSHOT

TABLE 56. Meso Scale Diagnostics: OPERATING SEGMENTS

TABLE 57. Randox Laboratories: COMPANY SNAPSHOT

TABLE 58. Randox Laboratories: OPERATING SEGMENTS

TABLE 59. Quanterix: COMPANY SNAPSHOT

TABLE 60. Quanterix: OPERATING SEGMENTS

TABLE 61. Bio-Techne Corporation: COMPANY SNAPSHOT

TABLE 62. Bio-Techne Corporation: OPERATING SEGMENTS

TABLE 63. Olink: COMPANY SNAPSHOT

TABLE 64. Olink: OPERATING SEGMENTS

TABLE 65. DiaSorin S.p.A.: COMPANY SNAPSHOT

TABLE 66. DiaSorin S.p.A.: OPERATING SEGMENTS

TABLE 67. Seegene: COMPANY SNAPSHOT

TABLE 68. Seegene: OPERATING SEGMENTS

TABLE 69. Promega Corporation: COMPANY SNAPSHOT

TABLE 70. Promega Corporation: OPERATING SEGMENTS

TABLE 71. Siemens Healthineers: COMPANY SNAPSHOT

TABLE 72. Siemens Healthineers: OPERATING SEGMENTS

TABLE 73. PerkinElmer Inc: COMPANY SNAPSHOT

TABLE 74. PerkinElmer Inc: OPERATING SEGMENTS

TABLE 75. Shimadzu Biotech: COMPANY SNAPSHOT

TABLE 76. Shimadzu Biotech: OPERATING SEGMENTS

TABLE 77. Antigenix America, Inc: COMPANY SNAPSHOT

TABLE 78. Antigenix America, Inc: OPERATING SEGMENTS

TABLE 79. Enzo Life Sciences, Inc: COMPANY SNAPSHOT

TABLE 80. Enzo Life Sciences, Inc: OPERATING SEGMENTS

TABLE 81. Boster Biological Technology: COMPANY SNAPSHOT

TABLE 82. Boster Biological Technology: OPERATING SEGMENTS

TABLE 83. AYOXXA Biosystems GmbH: COMPANY SNAPSHOT

TABLE 84. AYOXXA Biosystems GmbH: OPERATING SEGMENTS

TABLE 85. Cayman Chemical Company: COMPANY SNAPSHOT

TABLE 86. Cayman Chemical Company: OPERATING SEGMENTS

 

List of Figures (26 Figures)

Figure 1  Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries:  Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5  Market: Application-Based Estimation

Figure 6 Top 25 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2021

Figure 8 Import Data for Multiplex Assays, By Country, 2016–2021 (USD Thousand)

Figure 9 Export Data for Multiplex Assays, By Country, 2016–2021 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By Product and Service, 2019 vs. 2025 (USD Million)

Figure 12 Market, By Technology, 2019 vs. 2025 (USD Million)

Figure 13 Market, By Type, 2019 vs. 2025 (USD Million)

Figure 14 Market, By End-User, 2019 vs. 2025 (USD Million)

Figure 15 Market Share, By Application Type, 2019 vs. 2025

Figure 16 Geographical Snapshot of the  Market

Figure 17 Consumables to Witness Higher CAGR in  Market for Product and Service Segment during Forecast Period.

Figure 18 Flow Cytometry to Witness Higher CAGR in  Market for Technology Segment during Forecast Period.

Figure 19 Protein to Witness Higher CAGR in  Market for Type Segment during Forecast Period.

Figure 20 Pharmaceutical & Biotechnology Companies to Witness Higher CAGR in  Market for End-User Segment during Forecast Period.

Figure 21 Research & Development to Witness Higher CAGR in  Market for Application Segment during Forecast Period.

Figure 22 North America Accounted for the Largest Share of the  Market, By Regional Basis, in 2019

Figure 23  Market: Drivers, Restraints, Opportunities, and Challenges

Figure 24 North America:  Market Snapshot

Figure 25 Asia Pacific:  Market Snapshot

Figure 26 Vendor Dive: Evaluation Overview

 

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.